Bioplastics production capacity to quadruple by 2028
New figures published by the industry association European Bioplastics suggest a sharp increase in the production of sustainable plastics in the next two years and calls for policy support.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1352 entries already.
Entries by Thomas Gabrielczyk
AZmed closes €15m Series A financing
/in News/by Thomas GabrielczykParis-based AI-based medical imanging specialist AZmed SA has secured a €15min Series A financing led by Maison Worms, Techstars, and Tempact Ventures.
Bayer's Ask Bio unit starts Phase II heart failure gene therapy
/in News/by Thomas GabrielczykBayer SE subsidiary Asklepios BioPharmaceutical Inc. (AskBio) has started Phase II testing of AB-1002 (NAN-101) in patients with congestive heart failure.
German companies to revolutionise lab plastics market
/in News/by Thomas GabrielczykGerman Green Elephant Biotech has launched the world's first plant-based 96-well microtitre plate on the market.
AMPLY Discovery Ltd bags £1.4m funding to tackle complex diseases
/in News/by Thomas GabrielczykBelfast-based techbio company<b> </b>AMPLY Discovery Ltd announced today will make use of a £1.4m in grant funding to advance its AI-based drug discovery platform.
Cambridge university spin-out HutanBio Ltd bags £2.25m seed financing
/in News/by Thomas GabrielczykBritish-Malasian marine algae biofuel start-up HutanBio has secured an £2.25m seed investment to produce carbon negative biodiesel in brackish water.<br /><br /><br />
EU parliament votes in favour of New Genome Techniques
/in News/by Thomas GabrielczykThe European Parliament adopted its position for negotiations with Member States on the Commission's proposal on new genomic techniques (NGTs) in favour for using CRISPR/Cas as a new but now […]
EU parliament backs deregulation of New Genome Techniques
/in News/by Thomas GabrielczykAfter two "Yes"-votes in the European Parliament’s AGRI and ENVI committees, MEPs confirmed the European Commissions draft Regulation on New Genomic Technologies in plant breeding.<br /> <br /><br /> <br /><br […]
Jazz Pharmaceiticals licences KRAS blocker from Redx Pharma
/in News/by Thomas GabrielczykJazz Pharmaceuticals plc has entered an agreement with Redx Pharma to acquire commercialisation rights to Redx KRAS blockers, which include G12D selective and pan-KRAS molecules.<br /><br />
Jazz Pharmaceuticals licences KRAS blocker from Redx Pharma
/in News/by Thomas GabrielczykJazz Pharmaceuticals plc has entered an agreement with Redx Pharma to acquire commercialisation rights to Redx KRAS blockers, which include G12D selective and pan-KRAS molecules.<br /><br />